Use of the Flixene vascular access graft as an early cannulation solution

Journal of Vascular Surgery
Xavier BerardDominique Midy

Abstract

The primary end points of this study were safety and efficacy of early cannulation of the Flixene graft (Maquet-Atrium Medical, Hudson, NH). Secondary end points were complications and patency. This is a prospective single-center nonrandomized study. Study data included patient characteristics; history of vascular access; operative technique; interval between implantation and initial cannulation; complications; and patency at 1 month, 3 months, and every 6 months. Patency rates were estimated by the Kaplan-Meier method. Between January 2011 and September 2013, a total of 46 Flixene grafts were implanted in 44 patients (27 men) with a mean age of 63 years. The implantation site was the upper arm in 67% of cases, the forearm in 11%, and the thigh in 22%. Seven grafts were never cannulated during the study period. Of the remaining 39 grafts, 32 (82%) were successfully cannulated within the first week after implantation, including 16 (41%) on the first day. The median interval from implantation to initial cannulation was 2 days (interquartile range, 1-3 days). The median follow-up was 223.5 days (interquartile range, 97-600 days). Five hematomas occurred, but only one required surgical revision. Primary assisted and secondary paten...Continue Reading

References

Feb 1, 1997·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·V S SottiuraiE Reisin
Jul 15, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Rajiv SaranEric W Young
May 18, 2007·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Jan TordoirRaymond Vanholder
Nov 10, 2007·Seminars in Dialysis·Ivan D MayaMichael Allon
Nov 26, 2010·The Journal of Vascular Access·Christos LioupisDomenico Valenti
Feb 15, 2011·The Journal of Vascular Access·A Frederick SchildRavikumaran Nair
Feb 23, 2013·Journal of the American Society of Nephrology : JASN·Pietro RavaniMatthew T James
Jul 3, 2013·Journal of the American Society of Nephrology : JASN·Ranil N DeSilvaAlexander S Goldfarb-Rumyantzev
Sep 4, 2013·Nature Reviews. Nephrology·Christian Combe, Xavier Bérard
Nov 16, 2013·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Vanessa GrubbsKirsten L Johansen
Feb 18, 2014·The Journal of Vascular Access·Nathaniel ChiangThodur Vasudevan
Jul 2, 2014·The Journal of Vascular Access·Matteo TozziGabriele Piffaretti
Jul 27, 2014·Journal of the American Society of Nephrology : JASN·David A DrewDaniel E Weiner

❮ Previous
Next ❯

Citations

Mar 11, 2017·Techniques in Vascular and Interventional Radiology·Larry A Scher, Saadat Shariff
Mar 10, 2016·The Journal of Vascular Access·Nicolas OttavianiXavier Berard
May 31, 2018·The Journal of Vascular Access·Julien Al Shakarchi, Nicholas Inston
Mar 7, 2020·The Journal of Vascular Access·Rupesh Sutaria, James A Gilbert
Aug 20, 2020·The Journal of Vascular Access·Shawn M Gage, Heidi Reichert
Aug 20, 2019·The Journal of Vascular Access·Kathleen HillShilpa Jesudason
May 26, 2021·Scientific Reports·David B KingsmorePeter C Thomson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.